LANDOS BIOPHARMA INC
COM · CUSIP 515069102
0
institutional holders
-21 vs Q1 2023
—reported value*
0 new
0 added
0 reduced
21 sold out
net sold ≈ $4.6m (-15.5m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 32 |
| Q4 2022 | 24 |
| Q1 2023 | 21 |
| Q2 2023 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 9 | 19 |
| Q1 2023 | 7 | 13 |
| Q2 2023 | 0 | 21 |
Biggest buyers
| None |
Biggest sellers
| PERCEPTIVE ADVISORS LLC | Sold out | -14.9m |
| MACQUARIE GROUP LTD | Sold out | -147.2k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -91.5k |
| CITADEL ADVISORS LLC | Sold out | -86.1k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -79.2k |
| Warberg Asset Management LLC | Sold out | -73.5k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Sold out | -39.0k |
| BlackRock Inc. | Sold out | -33.8k |
| STATE STREET CORP | Sold out | -25.2k |
| VANGUARD GROUP INC | Sold out | -24.0k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|